Who owns FIRST WAVE BIOPHARMA INC?
- Ticker: ENTO
- CUSIP Number: 33749p408
Tip: Access positions for across all investors
Analyze quarterly positions in First Wave Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of First Wave Biopharma stock
Who bought or sold FIRST WAVE BIOPHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ground Swell Capital | 26k | $16k | 100% | Dec 2024 |
|
| Geode Capital Management | 20k | $12k | 24% | Dec 2024 |
|
| Two Sigma Securities | 10k | $6.3k | -62% | Dec 2024 |
|
| UBS Group | 7.5k | $7.5k | 752500% | Dec 2024 |
|
| Tower Research Capital | 5.1k | $3.1k | -32% | Dec 2024 |
|
| SBI Securities | 2.5k | $1.6k | 100% | Dec 2024 |
|
| FMR | 915.00 | $569.038500 | -5% | Dec 2024 |
|
| Bank of America Corporation | 39.00 | $24.000600 | 50% | Dec 2024 |
|
| Us Bancorp | 1.00 | $1.000000 | 0% | Dec 2024 |
|
Who sold out of First Wave Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Virtu Financial | Sep 2024 | 32k | $11k |
| Citadel Advisors | Sep 2024 | 10k | $3.5k |
| Kathleen S. Wright Associates | Sep 2024 | 1.00 | $0 |